High Court Won't Hear $70M Risperdal Verdict Challenge
The U.S. Supreme Court won't review a $70 million verdict against a Johnson & Johnson unit for a Pennsylvania man who grew enlarged breasts from taking Risperdal, the court said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article